October 09, 2025

GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025

GeneNovate | Call for Application 2025/2026 | APPLICATION DEADLINE: 09.11.2025

Got a startup idea? Curious about entrepreneurship? Then the GeneNovate program is the perfect place to start!

Objective

GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT), Biotech and Medicine. The program targets early-career scientists and physicians, such as advanced students, PhD candidates, and Postdocs, but it is also open to experienced researchers and medical professionals.

The GeneNovate program runs from December 2025 to June 2026 and includes a kick-off meeting in December, six theoretical input sessions (hybrid), six full-day workshops (onsite), team-based preparation and presentation of startup pitches and culminates in the Final Event in Munich. 

A key strength of the program lies in its collaborative approach, connecting participants across all GeneNovate locations in Germany. 

This comprehensive program is offered free of charge. 

Locations hosting the GeneNovate Workshops:

  • Berlin
  • Heidelberg
  • Munich
  • Region EAST (Dresden, Leipzig)
  • Region NORTH (Braunschweig, Göttingen, Hannover, …)
  • Region NRW 1 (Aachen, Bonn, Cologne, Düsseldorf, …)
  • Region NRW 2 (Bochum, Dortmund, Duisburg, Essen, …)
  • Region RHINE-MAIN (Mainz, …)
  • Region SOUTHWEST (Freiburg, Tübingen)

Apply now!

Registration for the remaining locations will open at a later date

Participate in Berlin: Submit your application here

Participate in Heidelberg: Submit your application here

Participate in Munich: Submit your application here

Participate in Region EAST (Dresden, Leipzig): Submit your application here

Participate in Region RHINE-MAIN (Mainz, …): Submit your application here


Program Framework

Kick-off Meeting | December 2025 

  • Participants will form teams and will be matched with mentors
  • Networking opportunity
  • Duration approx. 4 hours
  • Onsite participation at your selected location 

Theoretical Input Sessions | January 2026 to June 2026 

  • 6 theory sessions, held once per month, each lasting 4 hours
  • Onsite participation in Freiburg and Cologne, live stream for all other locations 

Workshops | January 2026 to June 2026 

  • Participants work in group exercises on the practical application of insights from the theoretical input sessions
  • Training from experts and experiences startups
  • 6 interactive sessions, held once per month, each lasting 6–8 hours
  • Onsite participation at your selected location 

Coaching Sessions with Mentors | January 2026 to June 2026 

  • Teams meet their mentor for about 1 hour after each workshop (in person or virtual) to prepare and rehearse the pitch for their startup
  • Approx. 8 hours in total 

Pre-selection of teams for the Final Event | June 2026 

  • Every team pitches their startup in front of a selection committee
  • Teams with the strongest pitches are selected to present at the Final Event in Munich 

Final Event 2026 in Munich | June 2026 

  • All participants, alumni, experts and mentors from all GeneNovate locations come together for networking, including the possibility to approach investors
  • Selected teams pitch their startup in front of investors
  • Panel discussions of experts and investors in the field
  • 1 full day in Munich

Our latest News

discover more
AlphaFold Database adds viral protein complexes to support pandemic preparedness

AlphaFold Database adds viral protein complexes to support pandemic preparedness

by Sera Guli The latest release includes protein structure predictions for thousands of viruses, which could improve the response to future outbreaks AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritises proteomes from viral families known to […]

European Commission grants €57 million to critical open data resources

European Commission grants €57 million to critical open data resources

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

Harnessing Synthetic Cellular Systems as Immune Cell Boosters

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp